Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance.
National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
Jessica
J
Glen
National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
Lefteris
L
Floros
Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK chris.day@newcastle.ac.uk.
Chris
C
Day
Winyates Health Centre, Redditch B98 0NR, UK.
Rachel
R
Pryke
D000075202:Contraindications; D006293:Health Promotion; D000070497:Healthy Lifestyle; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008103:Liver Cirrhosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D065626:Non-alcoholic Fatty Liver Disease / Q000175:diagnosis / Q000628:therapy*; D017410:Practice Guidelines as Topic; D012017:Referral and Consultation; D018570:Risk Assessment; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors